Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
IPO Year:
Exchange: NASDAQ
Website: apollomed.net
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2024 | $44.00 → $55.00 | Neutral → Buy | BofA Securities |
| 1/24/2024 | $45.00 | Buy | Stifel |
| 12/22/2023 | $41.00 | Hold | Truist |
| 10/17/2023 | $45.00 | Buy | BTIG Research |
| 4/12/2023 | $44.00 | Neutral | BofA Securities |
| 12/19/2022 | $40.00 | Buy | Lake Street |
| 9/21/2022 | Outperform | William Blair | |
| 1/11/2022 | $93.00 | Buy | Colliers Securities |
| 8/12/2021 | $92.00 | Equal-Weight | Barclays |
SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)
SC 13D/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)
SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)
SC 13G - Apollo Medical Holdings, Inc. (0001083446) (Subject)
SC 13D/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)
ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.
ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra
ALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all, today announced the following leadership transitions: Brandon Sim, the company's Co-CEO, has been named President and Chief Executive Officer, effective January 19, 2024.Dr. Thomas Lam will serve as Vice Chairman of the Board of Directors and is
ALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all, today announced it plans to change its name to Astrana Health, effective February 26, 2024. Alongside the planned corporate name change, the Company's common stock is intended to begin trading under the new symbol "ASTH" on the NASDAQ, effective February 26, 2024.
ALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that effective on January 23, 2024, the Compensation Committee of ApolloMed's Board of Directors (the "Committee") granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dinesh M. Kumar, M.D., the Company's newly-hired Chief Medical Officer, under the Apollo Medical Holdings, Inc. Empl
ALHAMBRA, Calif., Dec. 21, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Wednesday, January 10, 2024, including a presentation at 1:30 p.m. PT. The Company's presentation will be made available v
ALHAMBRA, Calif., Dec. 18, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that effective on December 15, 2023, the Compensation Committee of ApolloMed's Board of Directors (the "Committee") granted a total of 38,779 shares of restricted common stock to eight newly-hired non-executive employees, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan (the "Inducement Plan"). The Inducement Plan is used exclusive
ALHAMBRA, Calif., Nov. 13, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is participating in the BTIG Digital Health Forum, being held virtually, on Monday, November 20, 2023, including a panel discussion with Brandon Sim, Co-Chief Executive Officer, at 12:00 p.m. PT/3:00 p.m. ET. About Apollo Me
Wider Circle, a peer-based community health organization working with payers and providers to connect neighbors for better health, today announced that it has entered into a strategic partnership with Apollo Medical Holdings, Inc. ("ApolloMed") (NASDAQ:AMEH), a technology-powered healthcare company empowering providers to deliver high-quality, value-based care to all in their community, to deliver Enhanced Care Management (ECM) to high-need Medicaid members across the state of California. Under the joint venture relationship, the two organizations will provide comprehensive patient-centered care and Enhanced Care Management for Medicaid members with complex needs, an integral component of
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
3 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
S-8 - Apollo Medical Holdings, Inc. (0001083446) (Filer)
BofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously
Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00
Truist initiated coverage of Apollo Medical with a rating of Hold and set a new price target of $41.00
BTIG Research initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00
BofA Securities initiated coverage of Apollo Medical with a rating of Neutral and set a new price target of $44.00
Lake Street initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $40.00
William Blair initiated coverage of Apollo Medical with a rating of Outperform
Colliers Securities resumed coverage of Apollo Medical with a rating of Buy and set a new price target of $93.00
Barclays initiated coverage of Apollo Medical Hlgs with a rating of Equal-Weight and set a new price target of $92.00
ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Akido, a tech-integrated medical network reimagining healthcare from the ground up, announced that Eric Chin has been appointed Chief Financial Officer, effective immediately. Chin will work closely with Akido's co-founders as the company continues to bring its unique blend of AI-powered technology, best-in-class medical services and scalable preventive care programs to new markets across the U.S. Previously, Chin served as Chief Financial Officer at Apollo Medical Holdings (ApolloMed), a publicly traded physician-centric technology-powered healthcare company (NASDAQ:AMEH) that increased reported total revenue from approximately $520 million i
CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately. In this role, Mr. Shah will lead the Accounting, Finance, Revenue Cycle Management, and Investor Relations functions, playing a key role in driving TOI's public company success and executing the strategic growth plan. Mr. Shah succeeds Scott Dalgleish, who will serve as a senior advisor through a transition period. Mr. Shah joins TOI with fifteen years of industry leadership experience across public, private, and not-for-profit organizations. Most recently Mr. Shah served as chief fi
ALHAMBRA, Calif., Dec. 20, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced the appointments of Weili Dai, a renowned entrepreneur, technology executive and philanthropist, and J. Lorraine Estradas, R.N., B.S.N., M.P.H., an experienced leader in the Los Angeles healthcare industry, to its Board of Directors, effective December 31, 2021.
ALHAMBRA, Calif., Nov. 4, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced the appointment of Brandon Sim to the role of Co-Chief Executive Officer ("Co-CEO"), effective November 2, 2021. With this appointment, Kenneth Sim, M.D. will no longer serve as Co-CEO of ApolloMed but will continue in his role as Executive Chairman.
ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021. In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed's technology platform, business development, strategy and operations. Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a p
ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
Company to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter ended June 30, 2023. Brandon Sim, Co-Chief Executive Officer of ApolloMed, stated, "Our strong
ALHAMBRA, Calif., July 28, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter ended June 30, 2023, after the close of the stock market on Monday, August 7, 2023. The Company will discuss those results in a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
Company to Host Conference Call on Monday, May 8, 2023, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the first quarter ended March 31, 2023. Financial Highlights for First Quarter Ended March 31, 2023: Total revenue of
ALHAMBRA, Calif., April 26, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the first quarter ended March 31, 2023, after the close of the stock market on Monday, May 8, 2023. The Company will discuss those results in a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
Company to Host Conference Call on Friday, Feb. 24, 2023, at 5:30 a.m. PT/8:30 a.m. ET ALHAMBRA, Calif., Feb. 23, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2022. Financial Highlights for the Year Ended December 31, 2022: T
ALHAMBRA, Calif., Feb. 9, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the fourth quarter and year ended December 31, 2022, after the close of the stock market on Thursday, February 23, 2023. The Company will discuss those results in a conference call at 5:30 a.m. PT/8:30 a.m. ET on Friday, February 24, 2023.
ALHAMBRA, Calif., Oct. 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the third quarter and nine months ended September 30, 2022, after the close of the stock market on Thursday, November 3, 2022. The Company will discuss those results in a conference call at 5:30 a.m. PT/8:30 a.m. ET on Friday, November 4, 2022.
Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET ALHAMBRA, Calif., Aug. 4, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter and six months ended June 30, 2022. Financial Highlights for Second Quarter Ended June 30, 2022: Total revenue of $269.7 m
ALHAMBRA, Calif., July 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter and six months ended June 30, 2022, after the close of the stock market on Thursday, August 4, 2022. The Company will discuss those results in a conference call at 2 p.m. PT/5 p.m. ET that same day.
Apollo Medical Hlgs (NASDAQ:AMEH) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.15 by 73.33 percent. The company reported quarterly sales of $353.04 million which beat the analyst consensus estimate of $340.61 million by 3.65 percent. This is a 20.00 percent increase over sales of $294.21 million the same period last year.
Apollo Medical Hlgs (NASDAQ:AMEH) is set to give its latest quarterly earnings report on Tuesday, 2024-02-27. Here's what investors need to know before the announcement. Analysts estimate that Apollo Medical Hlgs will report an earnings per share (EPS) of $0.15. Apollo Medical Hlgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Past Earnings Performance Last quarter the company beat EPS by $0.14, which was followed by a 9.08% i
Jefferies analyst Jack Slevin initiates coverage on Apollo Medical Hlgs (NASDAQ:AMEH) with a Buy rating and announces Price Target of $50.
B of A Securities analyst Adam Ron upgrades Apollo Medical Hlgs (NASDAQ:AMEH) from Neutral to Buy and raises the price target from $44 to $55.
- SEC Filing
Stifel analyst Craig Jones initiates coverage on Apollo Medical Hlgs (NASDAQ:AMEH) with a Buy rating and announces Price Target of $45.
Truist Securities analyst Jailendra Singh initiates coverage on Apollo Medical Hlgs (NASDAQ:AMEH) with a Hold rating and announces Price Target of $41.